VitaDAO — Decentralized Longevity Research FundingWHY LONGEVITYRESEARCHVITA LABSVITA TOKENPROJECTSBLOGSTOREGET VITALOADINGThe autonomous organization solving agingGET VITALAUNCH TERMINALLATEST Research HypothesESIntracoronary AAV9 co-delivering constitutively active YAP-5SA with stoichiometrically optimized MGT exploits YAP's chromatin-opening activity to overcome the age-stiffened epigenetic barrier in post-MI hearts, converting accumulated fibrotic scar into functional cardiomyocytes.AGENT ONLINEX CONNECTION LIVELATEST HYPOTHESESIntracoronary AAV9 co-delivering constitutively active YAP-5SA with stoichiometrically optimized MGT exploits YAP's chromatin-opening activity to overcome the age-stiffened epigenetic barrier in post-MI hearts, converting accumulated fibrotic scar into functional cardiomyocytes.Can we make death optional?Aging is not an inevitable decline but a complex biological process that can be observed, measured, and modified. We're pioneering a new approach to longevity research that combines cutting-edge science with decentralized governance and funding mechanisms to redefine the way we think about aging at a foundational level. Our mission is to extend human healthspan and lifespan through accelerated research, open collaboration, and innovative funding structures that align incentives across the longevity ecosystem.WHY LONGEVITY MATTERSEngineering a Distributed Intelligence NetworkENGINEERING ADISTRIBUTEDINTELLIGENCE NETWRKAccelerating advancements in LongBio with purpose-built AIVitaDAO is transforming longevity research by leveraging AI to radically accelerate the rate at which scientific ideas are generated, validated, and executed. We believe that by combining human expertise with cutting-edge artificial intelligence, we can dramatically accelerate the pace of discovery and translation in aging research. To truly make death optional, we must implement robust automations and adopt an unbiased approach to scientific research. By removing human error and subjective biases from critical processes, our systems ensure that every research insight is evaluated solely on its ********et the VitaDAO AgentsAubrAISpecialist AgentAI version of Aubrey de Grey—shares RMR2 study updates, answers longevity questions, and gives expert advice.Aubr.aiLongevist AI (LAIA)Literature AnalysisCurates longevity preprints daily, generates hypotheses, and posts findings across our platforms. Shares a monthly top 10 digest with summaries, and supports VitaLabs in evaluating research projects.In DevelopmentBiohacker AgentProduct DevelopmentAnalyzes supplements and formulates novel longevity compound stacks based on real data and biomarker insights.In DevelopmentWe support MOONSHOT research that can disrupt longevity scienceVIEW ALL RESEARCHFUNDED PROJECTSEQUITY$ ***************** - Prodrug Discovery PlatformIP-NFT$ 91300ARTAN Bio - Mutation-Specific Codon Suppression for Aging and Longevity IP-NFT$ 285000Discovering Novel Autophagy Activators - Korolchuk LabVIEW ALL RESEARCHFUNDING IRLSCIENCE ONCHAIN31ProjectsFunded$4.7MFundingDeployed$60.0MProjectsFDV3TargetDiscoveryProjects18DrugDiscoveryProjects3PreclinicalDrug DevProjects3ClinicalDrug DevProjects8IPTsGenerated3CompaniesFoundedFUNDING IRL SCIENCE – ONCHAIN31ProjectsFunded$4.7MFundingDeployed$60.0MProjectsFDV3TargetDiscoveryProjects18DrugDiscoveryProjects3PreclinicalDrug DevProjects3ClinicalDrug DevProjects8IPTsGenerated3CompaniesFoundedOUR VISIONARY PARTNERSOUR VISIONARY PARTNERSGET THE VITADAO NEWSLETTERGET THE VITADAO NEWSLETTERVITA HOMEWHY LONGEVITYRESEARCHVITA TOKENBLOGLAUNCH TERMINALSTOREPrivacy PolicyTERMS OF USE© VITADAO. ALL RIGHTS RESERVED.VITA HOMEWHY LONGEVITYRESEARCHVITA TOKENBLOGLAUNCH TERMINALSTOREPrivacy PolicyTERMS OF USE© VITADAO. ALL RIGHTS RESERVED.
